Peru suspends clinical trials of Chinese COVID-19 vaccine | Inquirer News
Close  

Peru suspends clinical trials of Chinese COVID-19 vaccine

/ 03:10 PM December 12, 2020

A COVID-19 patient remains in the Intensive Care Unit of the Alberto Sabogal Sologuren Hospital, in Lima, on December 11, 2020, amid the new coronavirus pandemic. (Photo by ERNESTO BENAVIDES / AFP)

LIMA — Peru has temporarily suspended clinical trials of a COVID vaccine made by Chinese drug giant Sinopharm after detecting neurological problems in one of its test volunteers.

The National Institute of Health said Friday that it had decided to interrupt the trial after a volunteer had difficulty moving their arms, according to local media.

ADVERTISEMENT

“Several days ago we signaled, as we are required, to the regulatory authorities that one of our participants (in trials) presented neurological symptoms which could correspond to a condition called Guillain-Barre syndrome,” said chief researcher German Malaga in comments to the press.

Guillain-Barre syndrome is a rare and non-contagious disorder that affects the movement of the arms and legs. Peru declared a temporary health emergency in five regions in June last year following multiple cases.

FEATURED STORIES

In the 1970s a campaign to innoculate Americans against a supposedly devastating strain of swine flu ground to a halt after some 450 of those vaccinated developed the syndrome, which can also cause paralysis.

Peru’s clinical trials for the Sinopharm vaccine were due to conclude this week, after testing around 12,000 people.

If they are successful — which won’t be known until mid-2021 — the Peruvian government was expected to buy up to 20 million doses to inoculate two-thirds of its population.

60,000 across the globe have already taken the Sinopharm vaccine, including volunteers in Argentina, Russia, and Saudi Arabia.

Peru has one of the world’s highest per capita death rate from the virus, which as of Friday had caused 36,499 deaths and 979,111 infections.

The pandemic has hit the South American country’s economy hard, with GDP plunging more than 30 percent in the second quarter.

/MUF

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link .

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: China, COVID-19, Health, pandemic, Peru, Sinopharm, vaccine
For feedback, complaints, or inquiries, contact us.


© Copyright 1997-2021 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.